The researchers administered its active ingredient – known as beta-caryophyllin (E-BCP) - to mice with inflamed paws. In seven out of ten cases there was a subsequent improvement in the symptoms. E-BCP might possibly be of use against disorders such as osteoporosis and arteriosclerosis. The study has appeared on Monday, 23rd June in the “Proceedings of the National Academy of Sciences” (PNAS).
E-BCP is a typical ingredient of many spices and food plants. Hence it is also found in plants such as basil, rosemary, cinnamon, and black pepper. Every day, we consume up to 200 milligrams of this annular molecule.
No-one had previously realised that it can have a beneficial effect on the body. “Our results have revealed that E-BCP inhibits inflammation“, declared Professor Dr. Andreas Zimmer of the Life&Brain-Zentrum in Bonn. But that´s not all: “experiments on mice have shown that this substance is also effective against osteoporosis.”
Beta-caryophyllin docks on specific receptor structures in the cell membrane - the so-called cannabinoid-CB2 receptors, and produces a change in cell behaviour: for example, it will inhibit the cell´s production of phlogogenic signal substances. “We have used E-BCP to treat mice with paws swollen due to inflamations“, explained Dr. Jürg Gertsch of the ETH Zürich. “In up to 70 per cent of cases the swelling subsequently subsided”.
Pizza can´t make you high
Consequently, E-BCP could possibly form the basis for new drugs. One especial attraction for the pharmacological researcher is that this substance is so common in nature. But it has a further advantage in that, in contrast to other substances which affect the CB2 receptors, beta-caryophyllin does not lead to intoxication.
For this CB2 receptor has a "brother" by the name of CB1, which is best known to drug researchers. CB1 is found in the nerve cells of the brain, on which certain ingredients of the hemp plant can dock. What then happens is all too familiar to marihuana smokers.
Although CB1 and CB2 are not twins, they are nevertheless very closely related. Hence substances which stimulate CB2 often have an intoxicating effect. With E-BCP it is different, for this is the first known natural agent which binds specifically to CB2 and not CB1 – which explains why you can´t get high on pizza.
Both receptors are part of the so-called endocannabinoid system, which researchers are finding to be of increasing significance for a variety of disorders. If this system gets out of control it can result in cardiac disorders, allergies and chronic pain, or it could even affect the memory. “Endocannabinoids are formed by the body itself and maintain its equilibrium” explains Professor Zimmer. So in the case of an inflammation they act like a brake, preventing the immune system from over-reacting to the extent that its defensive reaction runs amok.
E-BCP might also help us to control such chronic disorders as Chrone´s disease – an inflammation of the intestinal tract. “This compound could become an important dietary factor for inhibiting such diseases of modern civilisation”, surmises Dr. Jürg Gertsch. However, anyone who in future spices all his food with oregano will not necessarily be any the healthier for it. “The endocannabinoid system comes into play when the equilibrium of the metabolic processes has been destroyed“, declares Professor Zimmer. “It is similar to the antidepressants in that, although they help for depressions, they don´t do anything to brighten the mood of a healthy person”.
Infants later diagnosed with autism follow adults’ gaze, but seldom initiate joint attention
24.05.2019 | Schwedischer Forschungsrat - The Swedish Research Council
When wheels and heads are spinning - DFG research project on motion sickness in automated driving
22.05.2019 | Technische Universität Berlin
A new assessment of NASA's record of global temperatures revealed that the agency's estimate of Earth's long-term temperature rise in recent decades is accurate to within less than a tenth of a degree Fahrenheit, providing confidence that past and future research is correctly capturing rising surface temperatures.
The most complete assessment ever of statistical uncertainty within the GISS Surface Temperature Analysis (GISTEMP) data product shows that the annual values...
Physicists at the University of Basel are able to show for the first time how a single electron looks in an artificial atom. A newly developed method enables them to show the probability of an electron being present in a space. This allows improved control of electron spins, which could serve as the smallest information unit in a future quantum computer. The experiments were published in Physical Review Letters and the related theory in Physical Review B.
The spin of an electron is a promising candidate for use as the smallest information unit (qubit) of a quantum computer. Controlling and switching this spin or...
Engineers at the University of Tokyo continually pioneer new ways to improve battery technology. Professor Atsuo Yamada and his team recently developed a...
With a quantum coprocessor in the cloud, physicists from Innsbruck, Austria, open the door to the simulation of previously unsolvable problems in chemistry, materials research or high-energy physics. The research groups led by Rainer Blatt and Peter Zoller report in the journal Nature how they simulated particle physics phenomena on 20 quantum bits and how the quantum simulator self-verified the result for the first time.
Many scientists are currently working on investigating how quantum advantage can be exploited on hardware already available today. Three years ago, physicists...
'Quantum technologies' utilise the unique phenomena of quantum superposition and entanglement to encode and process information, with potentially profound benefits to a wide range of information technologies from communications to sensing and computing.
However a major challenge in developing these technologies is that the quantum phenomena are very fragile, and only a handful of physical systems have been...
29.04.2019 | Event News
17.04.2019 | Event News
15.04.2019 | Event News
24.05.2019 | Physics and Astronomy
24.05.2019 | Medical Engineering
24.05.2019 | Life Sciences